Related references
Note: Only part of the references are listed.MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Daina Skiriute et al.
BMC CANCER (2012)
EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
Chunxi Wang et al.
CANCER RESEARCH (2012)
DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis
DanBo Wang et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2012)
INI1-Deficient Tumors: Diagnostic Features and Molecular Genetics
Travis J. Hollmann et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Malignant Rhabdoid Tumors Express Stem Cell Factors, Which Relate To the Expression of EZH2 and Id Proteins
Sriram Venneti et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
Roberta Ciarapica et al.
BMC MEDICINE (2011)
Epithelioid Sarcoma A Clinicopathologic and Immunohistochemical Analysis of 106 Cases From the French Sarcoma Group
Laila Chbani et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Hybrid Schwannoma/Perineurioma Clinicopathologic Analysis of 42 Distinctive Benign Nerve Sheath Tumors
Jason L. Hornick et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2
Stefan Burdach et al.
CELL CYCLE (2009)
Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor
Kenichi Kohashi et al.
HUMAN PATHOLOGY (2009)
The SWI/SNF complex and cancer
D. Reisman et al.
ONCOGENE (2009)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q. Cao et al.
ONCOGENE (2008)
Highly aggressive behavior of malignant rhabdoid tumor:: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR
Kenichi Kohashi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas
P Modena et al.
CANCER RESEARCH (2005)
Gene-promoter hypermethylation as a biomarker in lung cancer
SA Belinsky
NATURE REVIEWS CANCER (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors
F Zhang et al.
GENES CHROMOSOMES & CANCER (2002)
Share Paper
